QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS
- None.
- None.
Insights
Reviewing the financial results of Quaker Houghton, several key metrics stand out. First, the year-over-year decrease in Q4 net sales by 4% suggests a challenging market environment, likely impacting investor confidence. However, the increase in adjusted EBITDA by 13% in the same quarter indicates an improvement in operational efficiency. This dichotomy is critical for investors assessing the company's performance against market headwinds.
Furthermore, the full year net sales growth is modest, but the significant increase in net operating cash flow from $41.8 million in 2022 to $279.0 million in 2023 demonstrates strong cash management and operational improvements. The reduction in total gross debt and the new share repurchase program reflect a solid balance sheet and a commitment to returning value to shareholders, which are positive signals for the stock's attractiveness.
The decline in Q4 sales volume and the impact of the UAW strike highlight the importance of understanding external factors influencing the industrial process fluids market. The softening market conditions and customer order patterns have had a direct impact on sales volumes, which is an essential consideration for stakeholders evaluating the company's market position.
Moreover, the company's strategic initiatives, including the acquisition of IKVT, are aimed at enhancing its product offerings in high-performance lubricants and greases. This move could potentially open new revenue streams and strengthen its market presence in the automotive, aerospace and electronics industries, offering a long-term growth perspective.
Quaker Houghton's financial results must be contextualized within the broader economic environment. The impact of foreign currency translation on net sales indicates sensitivity to global exchange rate fluctuations, which is particularly relevant for a multinational corporation. Additionally, the expectation that current market conditions will persist into the first half of 2024 suggests a cautious economic outlook, which could influence the company's strategic planning and investment decisions.
The net debt to adjusted EBITDA ratio of 1.8x is a crucial leverage indicator, showing that the company is managing its debt responsibly relative to its earnings before interest, taxes, depreciation and amortization. This ratio is a vital sign of financial health for creditors and investors alike, impacting the company's ability to secure financing and invest in growth opportunities.
- Q4'23 net sales of
, net income of$467.1 million and earnings per diluted share of$20.2 million $1.12 - Q4'23 non-GAAP net income of
and non-GAAP earnings per diluted share of$31.9 million $1.78 - Delivered adjusted EBITDA of
in Q4'23, a$77.0 million 13% year-over-year increase - Full year net sales of
, net income of$1.95 billion and earnings per diluted share of$112.7 million $6.26 - Full year non-GAAP net income of
and non-GAAP earnings per diluted share of$137.6 million $7.65 - Delivered record full year adjusted EBITDA of
and operating cash flow of$320.4 million $279.0 million - Board of Directors approved a new share repurchase program of up to
of its common stock$150 million
Three Months Ended | Twelve Months Ended | ||||||
($ in thousands, except per share data) | 2023 | 2022 | 2023 | 2022 | |||
Net sales | $ 467,109 | $ 484,808 | $ 1,953,313 | $ 1,943,585 | |||
Net income (loss) attributable to Quaker Chemical Corporation | 20,198 | (75,957) | 112,748 | (15,931) | |||
Net income (loss) attributable to Quaker Chemical Corporation | 1.12 | (4.24) | 6.26 | (0.89) | |||
Non-GAAP net income * | 31,949 | 25,001 | 137,643 | 105,320 | |||
Non-GAAP earnings per diluted share * | 1.78 | 1.39 | 7.65 | 5.87 | |||
Adjusted EBITDA * | 76,964 | 67,923 | 320,379 | 257,150 | |||
* Refer to the Non-GAAP Measures and Reconciliations section below for additional information. |
Fourth Quarter 2023 Consolidated Results
Net sales in the fourth quarter of 2023 were
The Company reported net income in the fourth quarter of 2023 of
Andy Tometich, Chief Executive Officer and President, commented, "Quaker Houghton delivered solid fourth quarter results capping off a strong 2023. We generated record net sales and earnings in 2023, reflecting the considerable improvement in the profitability of our business while managing through a challenging market environment. These results, and our focus on working capital improvements, also led to record operating cash flow, which further strengthened our financial position. I am confident in our strategy and our ability to continue to outperform our markets, and we have the right team to further unlock our potential.
Looking ahead, we expect current market conditions to persist through the first half of 2024. We are encouraged by the progress we have made advancing our enterprise strategy, earning new business with our valued customers, and positioning the Company to deliver long-term profitable growth. We expect to benefit from these ongoing actions in 2024 and deliver another year of earnings growth. Additionally, our balance sheet and cash generation capabilities are strong and we remain committed to our capital allocation priorities which are aimed at enhancing shareholder value."
Fourth Quarter and Full Year 2023 Segment Results
The Company's fourth quarter and full year 2023 operating performance of each of its three reportable segments: (i)
Three Months Ended | Twelve Months Ended | ||||||
2023 | 2022 | 2023 | 2022 | ||||
Net Sales * | |||||||
$ 226,564 | $ 243,937 | $ 977,095 | $ 946,516 | ||||
EMEA | 135,745 | 135,769 | 571,347 | 562,508 | |||
104,800 | 105,102 | 404,871 | 434,561 | ||||
Total net sales | $ 467,109 | $ 484,808 | $ 1,953,313 | $ 1,943,585 | |||
Segment operating earnings * | |||||||
$ 61,756 | $ 59,547 | $ 266,036 | $ 223,629 | ||||
EMEA | 23,735 | 17,562 | 104,811 | 76,364 | |||
31,854 | 29,696 | 118,458 | 105,842 | ||||
Total segment operating earnings | $ 117,345 | $ 106,805 | $ 489,305 | $ 405,835 | |||
* Refer to the Segment Measures and Reconciliations section below for additional information. |
Net sales in the
The decline in selling price and product mix in the fourth quarter of 2023 compared to the prior year period in all segments primarily reflects index-based contracts and product mix, and partially offset by targeted pricing actions. Selling price and product mix increased in all segments for the full year 2023 compared to 2022. The decline in sales volumes in the
Compared to the third quarter of 2023, total company sales decreased approximately
Operating earnings increased in all three segments in the fourth quarter of 2023 compared to the prior year as well as for the full year 2023. This was primarily driven by an improvement in operating margins in all segments, consistent with the Company's ongoing margin improvement initiatives.
Cash Flow and Liquidity Highlights
The Company generated an additional
As of December 31, 2023, the Company's total gross debt was
During February 2024, the Company acquired I.K.V. Tribologie IKVT and its subsidiaries ("IKVT") for approximately 27.0 million EUR, or
Share Repurchase Program
On February 28, 2024, the Company's Board of Directors (the "Board") approved a new share repurchase program ("2024 Share Repurchase Program"), authorizing the Company to repurchase up to an aggregate of
Non-GAAP Measures and Reconciliations
The information included in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are indicative of future operating performance of the Company, and facilitate a comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not indicative of future operating performance or not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per share as discussed and reconciled below to the more comparable GAAP measures, may not be comparable to similarly named measures reported by other companies.
The Company presents EBITDA which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies. The Company also presents adjusted EBITDA which is calculated as EBITDA plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. In addition, the Company presents non-GAAP operating income which is calculated as operating income (loss) plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by investors, analysts, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net, and taxes on income (loss) before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by investors, analysts, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
As it relates to future projections for the Company as well as other forward-looking information described further above, the Company has not provided guidance for comparable GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable
The Company's reference to trailing twelve months adjusted EBITDA within this press release refers to the twelve month period ended December 31, 2023 adjusted EBITDA of
Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation. The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):
Three Months Ended | Twelve Months Ended | ||||||
Non-GAAP Operating Income and Margin Reconciliations: | 2023 | 2022 | 2023 | 2022 | |||
Operating income (loss) | $ 48,253 | $ (53,611) | $ 214,495 | $ 52,304 | |||
Combination, integration and other acquisition-related | — | 821 | — | 8,812 | |||
Restructuring and related charges, net | 1,554 | 3,733 | 7,588 | 3,163 | |||
Strategic planning expenses | 945 | 3,701 | 4,704 | 14,446 | |||
— | 304 | — | 2,487 | ||||
Impairment charges | — | 93,000 | — | 93,000 | |||
Other charges | 132 | 1,036 | 987 | 3,679 | |||
Non-GAAP operating income | $ 50,884 | $ 48,984 | $ 227,774 | $ 177,891 | |||
Non-GAAP operating margin (%) | 10.9 % | 10.1 % | 11.7 % | 9.2 % |
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and | Three Months Ended | Twelve Months Ended | |||||
2023 | 2022 | 2023 | 2022 | ||||
Net income (loss) attributable to Quaker Chemical Corporation | $ 20,198 | $ (75,957) | $ 112,748 | $ (15,931) | |||
Depreciation and amortization (a)(b) | 20,809 | 20,023 | 83,020 | 81,514 | |||
Interest expense, net | 11,955 | 12,351 | 50,699 | 32,579 | |||
Taxes on income before equity in net income of associated | 18,629 | 10,500 | 55,585 | 24,925 | |||
EBITDA | 71,591 | (33,083) | 302,052 | 123,087 | |||
Equity (income) loss in a captive insurance company | (1,342) | (772) | (2,090) | 1,427 | |||
Combination, integration and other acquisition-related | — | 602 | (475) | 10,990 | |||
Restructuring and related charges, net | 1,554 | 3,733 | 7,588 | 3,163 | |||
Strategic planning expenses | 945 | 3,701 | 4,704 | 14,446 | |||
Facility remediation recoveries, net | (1,127) | (700) | (2,141) | (1,804) | |||
Impairment charges | — | 93,000 | — | 93,000 | |||
Currency conversion impacts of hyper-inflationary economies | 4,980 | 401 | 7,849 | 1,617 | |||
— | 304 | — | 2,487 | ||||
Loss on extinguishment of debt | — | — | — | 6,763 | |||
Other charges | 363 | 737 | 2,892 | 1,974 | |||
Adjusted EBITDA | $ 76,964 | $ 67,923 | $ 320,379 | $ 257,150 | |||
Adjusted EBITDA margin (%) | 16.5 % | 14.0 % | 16.4 % | 13.2 % | |||
Adjusted EBITDA | $ 76,964 | $ 67,923 | $ 320,379 | $ 257,150 | |||
Less: Depreciation and amortization - adjusted (a)(b) | 20,809 | 20,023 | 83,020 | 81,514 | |||
Less: Interest expense, net | 11,955 | 12,351 | 50,699 | 32,579 | |||
Less: Taxes on income before equity in net income of | 12,251 | 10,548 | 49,017 | 37,737 | |||
Non-GAAP net income | $ 31,949 | $ 25,001 | $ 137,643 | $ 105,320 |
Three Months Ended | Twelve Months Ended | ||||||
Non-GAAP Earnings per Diluted Share Reconciliations: | 2023 | 2022 | 2023 | 2022 | |||
GAAP earnings (loss) per diluted share attributable to Quaker | $ 1.12 | $ (4.24) | $ 6.26 | $ (0.89) | |||
Equity (income) loss in a captive insurance company per | (0.08) | (0.04) | (0.12) | 0.08 | |||
Combination, integration and other acquisition-related | — | 0.02 | (0.03) | 0.49 | |||
Restructuring and related charges, net per diluted share | 0.07 | 0.15 | 0.32 | 0.13 | |||
Strategic planning expenses per diluted share | 0.04 | 0.17 | 0.21 | 0.63 | |||
Facility remediation recoveries, net per diluted share | (0.04) | (0.03) | (0.09) | (0.08) | |||
Impairment charges per diluted share | — | 5.19 | — | 5.19 | |||
Currency conversion impacts of hyper-inflationary economies | 0.28 | 0.02 | 0.44 | 0.09 | |||
— | — | — | 0.12 | ||||
Loss on extinguishment of debt per diluted share | — | — | — | 0.29 | |||
Other charges per diluted share | 0.01 | 0.03 | 0.12 | 0.08 | |||
Impact of certain discrete tax items per diluted share (d) | 0.38 | 0.11 | 0.54 | (0.26) | |||
Non-GAAP earnings per diluted share | $ 1.78 | $ 1.39 | $ 7.65 | $ 5.87 | |||
(a) | Combination, integration and other acquisition-related expenses (credits) in 2022 included certain legal, financial, and other advisory and consultant costs incurred in connection with the Combination integration activities. These amounts also include expense associated with the Company's other recent acquisitions, including certain legal, financial, and other advisory and consultant costs incurred in connection with due diligence. During the twelve months ended December 31, 2023 and 2022, the Company recorded income of |
(b) | Depreciation and amortization for both the three and twelve months ended December 31, 2023 and the three and twelve months ended December 31, 2022 included |
(c) | Taxes on income before equity in net income of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of Net income (loss) attributable to Quaker Chemical Corporation to adjusted EBITDA, above, determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility. This caption also includes the impact of specific tax charges and benefits in the three and twelve months ended December 31, 2023 and 2022, which the Company does not consider core or indicative of future performance. |
(d) | The impacts of certain discrete tax items include certain impacts of tax law changes, valuation allowance adjustments, uncertain tax positions and prior year true-ups, and the impact on certain intercompany asset transfers. For 2023 the impacts also include |
Segment Measures and Reconciliations
The Company's operating segments, which are consistent with its reportable segments, reflect the structure of the Company's internal organization, the method by which the Company's resources are allocated and the manner by which the chief operating decision maker assesses the Company's performance. The reportable segments presented in this Annual Report reflect the business structure the Company operated with during the periods presented, which was three reportable segments: (i)
During the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company's new structure includes three reportable segments: (i)
The following table presents information about the performance of the Company's reportable segments (dollars in thousands):
Three Months Ended | Twelve Months Ended | ||||||
2023 | 2022 | 2023 | 2022 | ||||
Net Sales | |||||||
$ 226,564 | $ 243,937 | $ 977,095 | $ 946,516 | ||||
EMEA | 135,745 | 135,769 | 571,347 | 562,508 | |||
104,800 | 105,102 | 404,871 | 434,561 | ||||
Total net sales | $ 467,109 | $ 484,808 | $ 1,953,313 | $ 1,943,585 | |||
Segment operating earnings | |||||||
$ 61,756 | $ 59,547 | $ 266,036 | $ 223,629 | ||||
EMEA | 23,735 | 17,562 | 104,811 | 76,364 | |||
31,854 | 29,696 | 118,458 | 105,842 | ||||
Total segment operating earnings | 117,345 | 106,805 | 489,305 | 405,835 | |||
Combination, integration and other acquisition-related expenses | — | (787) | — | (8,779) | |||
Restructuring and related charges, net | (1,554) | (3,767) | (7,588) | (3,163) | |||
Impairment charges | — | (93,000) | — | (93,000) | |||
Non-operating and administrative expenses | (52,397) | (47,947) | (206,398) | (187,841) | |||
Depreciation of corporate assets and amortization | (15,141) | (14,931) | (60,824) | (60,748) | |||
Operating income (loss) | 48,253 | (53,627) | 214,495 | 52,304 | |||
Other (expense) income, net | (2,114) | (2,087) | (10,672) | (12,607) | |||
Interest expense, net | (11,955) | (12,351) | (50,699) | (32,579) | |||
Income (loss) before taxes and equity in net income of | $ 34,184 | $ (68,065) | $ 153,124 | $ 7,118 |
Forward-Looking Statements
This press release contains "forward-looking statements" that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and the Securities Act of 1933, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on assumptions, projections and expectations about future events that we believe are reasonable based on currently available information,, including statements regarding the potential effects of the conflicts in
Conference Call
As previously announced, the Company's investor conference call to discuss its fourth quarter and full year 2023 performance is scheduled for Friday, March 1, 2024 at 8:30 a.m. ET. A live webcast of the conference call, together with supplemental information, can be accessed through the Company's Investor Relations website at investors.quakerhoughton.com. You can also access the conference call by dialing 877-269-7756.
About Quaker Houghton
Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge and customized services. With approximately 4,400 employees, including chemists, engineers and industry experts, we partner with our customers to improve their operations so they can run even more efficiently, even more effectively, whatever comes next. Quaker Houghton is headquartered in
QUAKER CHEMICAL CORPORATION | |||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||
(Unaudited; Dollars in thousands, except per share data) | |||||||
Three Months Ended | Twelve Months Ended | ||||||
2023 | 2022 | 2023 | 2022 | ||||
Net sales | $ 467,109 | $ 484,808 | $ 1,953,313 | $ 1,943,585 | |||
Cost of goods sold | 295,953 | 328,538 | 1,247,669 | 1,330,931 | |||
Gross profit | 171,156 | 156,270 | 705,644 | 612,654 | |||
Selling, general and administrative expenses | 121,349 | 112,327 | 483,561 | 455,408 | |||
Impairment charges | — | 93,000 | — | 93,000 | |||
Restructuring and related charges, net | 1,554 | 3,767 | 7,588 | 3,163 | |||
Combination, integration and other acquisition-related expenses | — | 787 | — | 8,779 | |||
Operating income (loss) | 48,253 | (53,611) | 214,495 | 52,304 | |||
Other expense, net | (2,114) | (2,087) | (10,672) | (12,607) | |||
Interest expense, net | (11,955) | (12,351) | (50,699) | (32,579) | |||
Income (loss) before taxes and equity in net income of | 34,184 | (68,049) | 153,124 | 7,118 | |||
Taxes on income (loss) before equity in net income of associated | 18,629 | 10,500 | 55,585 | 24,925 | |||
Income (loss) before equity in net income of associated | 15,555 | (78,549) | 97,539 | (17,807) | |||
Equity in net income of associated companies | 4,673 | 2,607 | 15,333 | 1,965 | |||
Net income (loss) | 20,228 | (75,942) | 112,872 | (15,842) | |||
Less: Net income attributable to noncontrolling interest | 30 | 15 | 124 | 89 | |||
Net income (loss) attributable to Quaker Chemical Corporation | $ 20,198 | $ (75,957) | $ 112,748 | $ (15,931) | |||
Per share data: | |||||||
Net income (loss) attributable to Quaker Chemical Corporation | $ 1.12 | $ (4.24) | $ 6.27 | $ (0.89) | |||
Net income (loss) attributable to Quaker Chemical Corporation | $ 1.12 | $ (4.24) | $ 6.26 | $ (0.89) | |||
Basic weighted average common shares outstanding | 17,901,225 | 17,857,840 | 17,892,461 | 17,841,487 | |||
Diluted weighted average common shares outstanding | 17,921,070 | 17,869,452 | 17,914,809 | 17,856,492 |
QUAKER CHEMICAL CORPORATION | |||
CONSOLIDATED BALANCE SHEETS | |||
(Unaudited; Dollars in thousands, except par value) | |||
December 31, | |||
2023 | 2022 | ||
ASSETS | |||
Current assets | |||
Cash and cash equivalents | $ 194,527 | $ 180,963 | |
Accounts receivable, net | 444,950 | 472,888 | |
Inventories, net | 233,857 | 284,848 | |
Prepaid expenses and other current assets | 54,555 | 55,438 | |
Total current assets | 927,889 | 994,137 | |
Property, plant and equipment, net | 207,811 | 198,595 | |
Right of use lease assets | 38,614 | 43,766 | |
Goodwill | 512,518 | 515,008 | |
Other intangible assets, net | 896,721 | 942,925 | |
Investments in associated companies | 101,151 | 88,234 | |
Deferred tax assets | 10,737 | 11,218 | |
Other non-current assets | 18,770 | 27,739 | |
Total assets | $ 2,714,211 | $ 2,821,622 | |
LIABILITIES AND EQUITY | |||
Current liabilities | |||
Short-term borrowings and current portion of long-term debt | $ 23,444 | $ 19,245 | |
Accounts payable | 184,813 | 193,983 | |
Dividends payable | 8,186 | 7,808 | |
Accrued compensation | 55,194 | 39,834 | |
Accrued restructuring | 3,350 | 5,483 | |
Accrued pension and postretirement benefits | 2,208 | 1,560 | |
Other accrued liabilities | 90,315 | 86,873 | |
Total current liabilities | 367,510 | 354,786 | |
Long-term debt | 730,623 | 933,561 | |
Long-term lease liabilities | 22,937 | 26,967 | |
Deferred tax liabilities | 146,957 | 160,294 | |
Non-current accrued pension and postretirement benefits | 29,457 | 28,765 | |
Other non-current liabilities | 31,805 | 38,664 | |
Total liabilities | 1,329,289 | 1,543,037 | |
Equity | |||
Common stock, | 17,992 | 17,950 | |
Capital in excess of par value | 940,101 | 928,288 | |
Retained earnings | 550,641 | 469,920 | |
Accumulated other comprehensive loss | (124,415) | (138,240) | |
Total Quaker shareholders' equity | 1,384,319 | 1,277,918 | |
Noncontrolling interest | 603 | 667 | |
Total equity | 1,384,922 | 1,278,585 | |
Total liabilities and equity | $ 2,714,211 | $ 2,821,622 |
QUAKER CHEMICAL CORPORATION | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
(Unaudited; Dollars in thousands) | |||
Year Ended December 31, | |||
2023 | 2022 | ||
Cash flows from operating activities | |||
Net income (loss) | $ 112,872 | $ (15,842) | |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||
Amortization of debt issuance costs | 1,413 | 2,942 | |
Depreciation and amortization | 81,987 | 80,467 | |
Equity in undistributed earnings of associated companies, net of dividends | (11,149) | 1,005 | |
Deferred income taxes | (11,442) | (10,552) | |
Uncertain tax positions (non-deferred portion) | (644) | (6,398) | |
Deferred compensation and other, net | 5,711 | 2,613 | |
Share-based compensation | 14,605 | 11,666 | |
Loss on extinguishment of debt | — | 5,246 | |
Gain on disposal of property, plant, equipment and other assets | (1,307) | (168) | |
Impairment charges | — | 93,000 | |
Combination and other acquisition-related expenses, net of payments | — | (4,460) | |
Restructuring and related charges | 7,588 | 3,163 | |
Pension and other postretirement benefits | (2,079) | (7,964) | |
Increase (decrease) in cash from changes in current assets and current liabilities, net of | |||
Accounts receivable | 32,169 | (59,112) | |
Inventories | 49,751 | (29,858) | |
Prepaid expenses and other current assets | (21) | 3,705 | |
Change in restructuring liabilities | (9,786) | (1,532) | |
Accounts payable and accrued liabilities | 5,937 | (23,439) | |
Estimated taxes on income | 3,415 | (2,688) | |
Net cash provided by operating activities | 279,020 | 41,794 | |
Cash flows from investing activities | |||
Investments in property, plant and equipment | (38,800) | (28,539) | |
Payments related to acquisitions, net of cash acquired | — | (13,115) | |
Proceeds from disposition of assets | 11,179 | 1,463 | |
Net cash used in investing activities | (27,621) | (40,191) | |
Cash flows from financing activities | |||
Payments of long-term debt | (38,932) | (673,203) | |
Proceeds from long-term debt | — | 750,000 | |
Repayments on revolving credit facilities, net | (164,769) | (16,281) | |
Repayments on other debt, net | (506) | (1,629) | |
Financing-related debt issuance costs | — | (3,734) | |
Dividends paid | (31,650) | (30,103) | |
Stock options exercised, other | (2,749) | (378) | |
Net cash (used in) provided by financing activities | (238,606) | 24,672 | |
Effect of foreign exchange rate changes on cash | 771 | (10,488) | |
Net increase in cash, cash equivalents and restricted cash | 13,564 | 15,787 | |
Cash, cash equivalents and restricted cash at the beginning of the period | 180,963 | 165,176 | |
Cash, cash equivalents and restricted cash at the end of the period | $ 194,527 | $ 180,963 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/quaker-houghton-announces-fourth-quarter-and-full-year-2023-results-302076294.html
SOURCE Quaker Houghton
FAQ
What were Quaker Houghton's Q4'23 net sales figures?
What was Quaker Houghton's net income for Q4'23?
What were Quaker Houghton's earnings per diluted share in Q4'23?
What were Quaker Houghton's full-year net sales for 2023?
What was Quaker Houghton's full-year net income for 2023?
What was Quaker Houghton's full-year earnings per diluted share for 2023?
What was Quaker Houghton's adjusted EBITDA in Q4'23?
What was the year-over-year percentage increase in Quaker Houghton's adjusted EBITDA for Q4'23?
Did Quaker Houghton report a record full-year adjusted EBITDA for 2023?